The Role of Medical Affairs in Shaping Brand Development - PowerPoint PPT Presentation

About This Presentation
Title:

The Role of Medical Affairs in Shaping Brand Development

Description:

Drug to Development Approval. 3-10 Years Research Development. Focus. Time. Division * Rough examples for discussion. Clinical Commercial Optimization Planning Steps ... – PowerPoint PPT presentation

Number of Views:1553
Avg rating:3.0/5.0
Slides: 8
Provided by: SHar124
Category:

less

Transcript and Presenter's Notes

Title: The Role of Medical Affairs in Shaping Brand Development


1
The Role of Medical Affairs in Shaping Brand
Development
  • PRINCETON PHARMA COMPLIANCE CONFERENCE

Michael Edwin Kafrissen, MD, MSPH
June 7, 2004
2
Key Themes
  • Changing Environment Changing Roles for Medical
    Affairs
  • Medical Affairs and Its Partners How the
    Elements of the Company Differ
  • Clinical Commercial Optimization Planning vs.
    Reaction
  • Enablers and Obstacles

3
Medical Affairs and HCC
  • Clinical commercial optimization requires
    specialized skills, involvement beginning in
    development and extending through life cycle.
  • A mastery of HCC facilitates not only legal and
    ethical behavior but also commercial success.

4
Changing Environment Changing Roles
  1. What we demonstrate is what we can say label,
    publication, evidence-base.
  2. HCC codifies business ethics and good science
    neither meets universal agreement.
  3. Pipeline, development costs, margins the
    product/molecule life cycle value.
  4. Customer types, customer expectations.

5
Medical Affairs and Partners Time Space
Division Time Focus
Research Development 3-10 Years Drug to Development Approval
Medical Affairs Crisis-7 Years Life Cycle
New Product 2-3 Years Launch
Brand ¼ - 1 Year Market Share
Sales Week 1 Year Comp. Plan
Rough examples for discussion.
6
Clinical Commercial Optimization Planning Steps
  • Understand molecule, clinical issues, customer
    drivers.
  • Early advice from experts, KOLs, promotional
    partners.
  • Develop clinical, epidemiologic, outcomes, and
    publication plan.
  • Influence requires expertise team may evolve.
  • Execution requires expertise team may evolve.
  • Information must be in place to permit
    appropriate adoption, including CME.
  • Flexibility new data, new technology,
    competitive activity.

7
  • As customers consolidate, evidence is demanded,
    and regulation clarifies, Medical Affairs role
    will grow in life cycle planning, execution,
    communication, and episodic issue management.
  • Each product/molecule must be characterized
    appropriately and developed to its optimal
    extent. A skilled and enabled Medical Affairs
    function is the best investment for the
    foreseeable future.
Write a Comment
User Comments (0)
About PowerShow.com